SEC Form 4 · accession 0001693042-18-000001
Genesis Healthcare, Inc. · GEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul David Bach
Officer — COO
Period of report
Jun 5, 2018
Accepted (ET)
Jun 7, 2018 · 11:06 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001351051
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF2 | Jun 5, 2018 | S | 10,131 | $2.1913 | D | 571,140 | D | |
| Class A Common StockF4 | Jun 6, 2018 | A | 185,900 | $0.00 | A | 757,040 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected to satisfy the reporting person's income tax obligations with respect to the vesting of a restricted stock unit award.
- F2Includes 212,332 unvested restricted stock units that have not yet been paid in shares of the Issuer's Class A Common Stock.
- F3Grant of restricted stock units under the Issuer's 2015 Omnibus Equity Incentive Plan.
- F4Includes 398,232 unvested restricted stock units that have not yet been paid in shares of the Issuer's common stock.